Exact Mass: 433.1449

Exact Mass Matches: 433.1449

Found 93 metabolites which its exact mass value is equals to given mass value 433.1449, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Dihydrozeatin riboside monophosphate

Dihydrozeatin riboside monophosphate

C15H24N5O8P (433.1362)


   

Tolmetin glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-({2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetyl}oxy)oxane-2-carboxylic acid

C21H23NO9 (433.1373)


Tolmetin glucuronide belongs to the family of Glucuronic Acid Derivatives. These are compounds containing a glucuronic acid moeity (or a derivative), which consists of a glucose moiety with the C6 carbon oxidized to a carboxylic acid.

   

4-Hydroxy-5-[3-(sulfooxy)phenyl]pentanoylcarnitine

3-({4-hydroxy-5-[3-(sulfooxy)phenyl]pentanoyl}oxy)-4-(trimethylazaniumyl)butanoate

C18H27NO9S (433.1406)


4-hydroxy-5-[3-(sulfooxy)phenyl]pentanoylcarnitine is an acylcarnitine. More specifically, it is an 4-hydroxy-5-[3-(sulfooxy)phenyl]pentanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-hydroxy-5-[3-(sulfooxy)phenyl]pentanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-hydroxy-5-[3-(sulfooxy)phenyl]pentanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2S)-2-[[4-[[(2R)-2-Amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoic acid

(2S)-2-[[4-[[(2R)-2-Amino-3-sulphanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulphanylbutanoic acid

C21H27N3O3S2 (433.1494)


   

N-(((1-(2-(Diethylamino)ethyl)amino)-9-oxo-9H-thioxanthen-4-yl)methyl)methanesulfonamide

N-[(1-{[2-(diethylamino)ethyl]amino}-9-oxo-9H-thioxanthen-4-yl)methyl]methanesulphonamide

C21H27N3O3S2 (433.1494)


   
   

Dihydrozeatin riboside-5-monophosphate

Dihydrozeatin riboside-5-monophosphate

C15H24N5O8P (433.1362)


   
   
   

Ala Asn Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-carboxypropanamido]butanedioic acid

C15H23N5O10 (433.1445)


   

Dihydrozeatin riboside-5-monophosphate sodium salt

Dihydrozeatin riboside-5-monophosphate sodium salt

C15H24N5O8P (433.1362)


   

12-[(2,4-dimethoxyphenyl)carbonyl]-6a,6b,10,11,11a,12-hexahydro-8,11-epoxyoxepino[4,5:3,4]pyrrolo[1,2-a]quinolin-7(8H)-one

12-[(2,4-dimethoxyphenyl)carbonyl]-6a,6b,10,11,11a,12-hexahydro-8,11-epoxyoxepino[4,5:3,4]pyrrolo[1,2-a]quinolin-7(8H)-one

C25H23NO6 (433.1525)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.276 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.275 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.279

   
   

Ala Asp Asp Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]-3-carboxypropanamido]-3-carbamoylpropanoic acid

C15H23N5O10 (433.1445)


   

Ala Asp Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]-3-carbamoylpropanamido]butanedioic acid

C15H23N5O10 (433.1445)


   

Mefenamic acid Metabolite (b-D-Glucopyranuronic acid, 1-[2-[[3-(hydroxymethyl)-2-methylphenyl]amino]

Mefenamic acid Metabolite (b-D-Glucopyranuronic acid, 1-[2-[[3-(hydroxymethyl)-2-methylphenyl]amino]

C21H23NO9 (433.1373)


   

Asp Ala Asp Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]-3-carboxypropanamido]-3-carbamoylpropanoic acid

C15H23N5O10 (433.1445)


   

Asp Ala Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]-3-carbamoylpropanamido]butanedioic acid

C15H23N5O10 (433.1445)


   

Asp Asp Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]propanamido]-3-carbamoylpropanoic acid

C15H23N5O10 (433.1445)


   

Asp Asp Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]acetamido}-4-carbamoylbutanoic acid

C15H23N5O10 (433.1445)


   

Asp Asp Asn Ala

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C15H23N5O10 (433.1445)


   

Asp Asp Gln Gly

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-{[(1S)-3-carbamoyl-1-[(carboxymethyl)carbamoyl]propyl]carbamoyl}propanoic acid

C15H23N5O10 (433.1445)


   

Asp Glu Gly Asn

(4S)-4-[(2S)-2-amino-3-carboxypropanamido]-4-[({[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}methyl)carbamoyl]butanoic acid

C15H23N5O10 (433.1445)


   

Asp Glu Asn Gly

(4S)-4-[(2S)-2-amino-3-carboxypropanamido]-4-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}butanoic acid

C15H23N5O10 (433.1445)


   

Asp Gly Asp Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-3-carboxypropanamido]-4-carbamoylbutanoic acid

C15H23N5O10 (433.1445)


   

Asp Gly Glu Asn

(4S)-4-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C15H23N5O10 (433.1445)


   

Asp Gly Asn Glu

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-3-carbamoylpropanamido]pentanedioic acid

C15H23N5O10 (433.1445)


   

Asp Gly Gln Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-4-carbamoylbutanamido]butanedioic acid

C15H23N5O10 (433.1445)


   

Asp Asn Ala Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]propanamido]butanedioic acid

C15H23N5O10 (433.1445)


   

Asp Asn Asp Ala

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C15H23N5O10 (433.1445)


   

Asp Asn Glu Gly

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-4-[(carboxymethyl)carbamoyl]butanoic acid

C15H23N5O10 (433.1445)


   

Asp Asn Gly Glu

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]acetamido}pentanedioic acid

C15H23N5O10 (433.1445)


   

Asp Gln Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carbamoylbutanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C15H23N5O10 (433.1445)


   

Asp Gln Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carbamoylbutanamido]acetamido}butanedioic acid

C15H23N5O10 (433.1445)


   

Glu Asp Gly Asn

(4S)-4-amino-4-{[(1S)-1-[({[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}methyl)carbamoyl]-2-carboxyethyl]carbamoyl}butanoic acid

C15H23N5O10 (433.1445)


   

Glu Asp Asn Gly

(4S)-4-amino-4-{[(1S)-1-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}-2-carboxyethyl]carbamoyl}butanoic acid

C15H23N5O10 (433.1445)


   

Glu Gly Asp Asn

(4S)-4-amino-4-[({[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-carboxyethyl]carbamoyl}methyl)carbamoyl]butanoic acid

C15H23N5O10 (433.1445)


   

Glu Gly Asn Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carboxybutanamido]acetamido}-3-carbamoylpropanamido]butanedioic acid

C15H23N5O10 (433.1445)


   

Glu Asn Asp Gly

(4S)-4-amino-4-{[(1S)-2-carbamoyl-1-{[(1S)-2-carboxy-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C15H23N5O10 (433.1445)


   

Glu Asn Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carbamoylpropanamido]acetamido}butanedioic acid

C15H23N5O10 (433.1445)


   

Gly Asp Asp Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-3-carboxypropanamido]-4-carbamoylbutanoic acid

C15H23N5O10 (433.1445)


   

Gly Asp Glu Asn

(4S)-4-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C15H23N5O10 (433.1445)


   

Gly Asp Asn Glu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-3-carbamoylpropanamido]pentanedioic acid

C15H23N5O10 (433.1445)


   

Gly Asp Gln Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-4-carbamoylbutanamido]butanedioic acid

C15H23N5O10 (433.1445)


   

Gly Glu Asp Asn

(4S)-4-(2-aminoacetamido)-4-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-carboxyethyl]carbamoyl}butanoic acid

C15H23N5O10 (433.1445)


   

Gly Glu Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carboxybutanamido]-3-carbamoylpropanamido]butanedioic acid

C15H23N5O10 (433.1445)


   

Gly Asn Asp Glu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-carboxypropanamido]pentanedioic acid

C15H23N5O10 (433.1445)


   

Gly Asn Glu Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-4-carboxybutanamido]butanedioic acid

C15H23N5O10 (433.1445)


   

Gly Gln Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-carboxypropanamido]butanedioic acid

C15H23N5O10 (433.1445)


   

Asn Ala Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-carboxypropanamido]butanedioic acid

C15H23N5O10 (433.1445)


   

Asn Asp Ala Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]propanamido]butanedioic acid

C15H23N5O10 (433.1445)


   

Asn Asp Asp Ala

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C15H23N5O10 (433.1445)


   

Asn Asp Glu Gly

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-4-[(carboxymethyl)carbamoyl]butanoic acid

C15H23N5O10 (433.1445)


   

Asn Asp Gly Glu

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]acetamido}pentanedioic acid

C15H23N5O10 (433.1445)


   

Asn Glu Asp Gly

(4S)-4-[(2S)-2-amino-3-carbamoylpropanamido]-4-{[(1S)-2-carboxy-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}butanoic acid

C15H23N5O10 (433.1445)


   

Asn Glu Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carboxybutanamido]acetamido}butanedioic acid

C15H23N5O10 (433.1445)


   

Asn Gly Asp Glu

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-carboxypropanamido]pentanedioic acid

C15H23N5O10 (433.1445)


   

Asn Gly Glu Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-4-carboxybutanamido]butanedioic acid

C15H23N5O10 (433.1445)


   

Gln Asp Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carboxypropanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C15H23N5O10 (433.1445)


   

Gln Asp Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carboxypropanamido]acetamido}butanedioic acid

C15H23N5O10 (433.1445)


   

Gln Gly Asp Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-carboxypropanamido]butanedioic acid

C15H23N5O10 (433.1445)


   

Tolmetin glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-{1-methyl-5-[(4-methylphenyl)carbonyl]-1H-pyrrol-2-yl}acetyl)oxy]oxane-2-carboxylic acid

C21H23NO9 (433.1373)


   

(4R,12aS)-N-(2,4-Difluorobenzyl)-7-Methoxy-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide

(4R,12aS)-N-(2,4-Difluorobenzyl)-7-Methoxy-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide

C21H21F2N3O5 (433.1449)


   

Fmoc-N(Hmb)-Gly-OH

Fmoc-N(Hmb)-Gly-OH

C25H23NO6 (433.1525)


   

9-(4-bromophenyl)-3,6-di-tert-butyl-9H-carbazole

9-(4-bromophenyl)-3,6-di-tert-butyl-9H-carbazole

C26H28BrN (433.1405)


   

2-[2-[4-[(2-chloroethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium dihydrogen phosphate

2-[2-[4-[(2-chloroethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium dihydrogen phosphate

C22H27ClN2O3P++ (433.1448)


   

9-AMino-(9-deoxy)epi-dihydroquinine trihydrochloride

9-AMino-(9-deoxy)epi-dihydroquinine trihydrochloride

C20H30Cl3N3O (433.1454)


   

ALS-8176

Lumicitabine

C18H25ClFN3O6 (433.1416)


C471 - Enzyme Inhibitor > C25995 - RNA Polymerase Inhibitor

   

Hydroxychloroquine sulfate

Hydroxychloroquine sulfate

C18H28ClN3O5S (433.1438)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

N-(((1-(2-(Diethylamino)ethyl)amino)-9-oxo-9H-thioxanthen-4-yl)methyl)methanesulfonamide

N-(((1-(2-(Diethylamino)ethyl)amino)-9-oxo-9H-thioxanthen-4-yl)methyl)methanesulfonamide

C21H27N3O3S2 (433.1494)


   

(2S)-2-[[4-[[(2R)-2-Amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoic acid

(2S)-2-[[4-[[(2R)-2-Amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoic acid

C21H27N3O3S2 (433.1494)


   

N-(3-chloropyridin-2-yl)-N-[(3R)-piperidin-3-yl]-4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzamide

N-(3-chloropyridin-2-yl)-N-[(3R)-piperidin-3-yl]-4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzamide

C22H20ClN7O (433.1418)


   
   

(2S)-2-[[4-[[(2R)-2-Amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoic acid

(2S)-2-[[4-[[(2R)-2-Amino-3-sulphanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulphanylbutanoic acid

C21H27N3O3S2 (433.1494)


   

4-Hydroxy-5-[3-(sulfooxy)phenyl]pentanoylcarnitine

4-Hydroxy-5-[3-(sulfooxy)phenyl]pentanoylcarnitine

C18H27NO9S (433.1406)


   

2-[[7-(4-Methoxyphenyl)-5-phenyl-4-pyrrolo[2,3-d]pyrimidinyl]thio]propanoic acid ethyl ester

2-[[7-(4-Methoxyphenyl)-5-phenyl-4-pyrrolo[2,3-d]pyrimidinyl]thio]propanoic acid ethyl ester

C24H23N3O3S (433.146)


   

3-[2-[(1,5-Dimethyl-3-oxo-2-phenyl-4-pyrazolyl)amino]-2-oxoethyl]-4-oxo-1-phthalazinecarboxylic acid

3-[2-[(1,5-Dimethyl-3-oxo-2-phenyl-4-pyrazolyl)amino]-2-oxoethyl]-4-oxo-1-phthalazinecarboxylic acid

C22H19N5O5 (433.1386)


   

[1-[1-[4-(difluoromethoxy)phenyl]-2,5-dimethylpyrrol-3-yl]-1-oxopropan-2-yl] 6-oxo-4,5-dihydro-1H-pyridazine-3-carboxylate

[1-[1-[4-(difluoromethoxy)phenyl]-2,5-dimethylpyrrol-3-yl]-1-oxopropan-2-yl] 6-oxo-4,5-dihydro-1H-pyridazine-3-carboxylate

C21H21F2N3O5 (433.1449)


   

1-(4-methylphenyl)-3-[[2-(4-methylphenyl)-1,3-dioxo-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]thiourea

1-(4-methylphenyl)-3-[[2-(4-methylphenyl)-1,3-dioxo-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]thiourea

C24H23N3O3S (433.146)


   

N-[(2R,3S,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

N-[(2R,3S,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)


   

N-[(2R,3R,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

N-[(2R,3R,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)


   

N-[(2R,3S,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

N-[(2R,3S,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)


   

N-[(2R,3R,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

N-[(2R,3R,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)


   

N-[(2S,3S,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

N-[(2S,3S,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)


   

N-[(2S,3S,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

N-[(2S,3S,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)


   

N-[(2S,3R,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

N-[(2S,3R,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)


   

N-[(2S,3R,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

N-[(2S,3R,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)


   

5-(3,4-Dimethoxyphenyl)-4-(furan-2-carbonyl)-1-(2-phenylethyl)pyrrolidine-2,3-dione

5-(3,4-Dimethoxyphenyl)-4-(furan-2-carbonyl)-1-(2-phenylethyl)pyrrolidine-2,3-dione

C25H23NO6 (433.1525)


   

G907

G907

C26H24ClNO3 (433.1445)


G907 is a selective antagonist of ATP-binding cassette (ABC) transporter MsbA with anti-microbial activity. G907 inhibits E. coli MsbA with an IC50 value of 18 nM. G907 traps MsbA in an inward-facing, lipopolysaccharide-bound conformation by wedging into an architecturally conserved transmembrane pocket[1][2].

   

PHT-7.3

PHT-7.3

C24H23N3O3S (433.146)


PHT-7.3 is a selective inhibitor of connector enhancer of kinase suppressor of Ras 1 (Cnk1) pleckstrin homology (PH) domain (Kd=4.7 μM). PHT-7.3 inhibits mut-KRas, but not wild-type KRas cancer cell and tumor growth and signaling. PHT-7.3 has antitumor activity[1].

   

[(2r,3r,4r,5s)-3,4-dihydroxy-5-(6-{[(3s)-4-hydroxy-3-methylbutyl]amino}purin-9-yl)oxolan-2-yl]methoxyphosphonic acid

[(2r,3r,4r,5s)-3,4-dihydroxy-5-(6-{[(3s)-4-hydroxy-3-methylbutyl]amino}purin-9-yl)oxolan-2-yl]methoxyphosphonic acid

C15H24N5O8P (433.1362)


   

n-{5,5-dichloro-4-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl}-n,3-dimethylbutanamide

n-{5,5-dichloro-4-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl}-n,3-dimethylbutanamide

C19H29Cl2N3O2S (433.1357)


   

4,4-dichloro-n,3-dimethyl-n-{4-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl}butanamide

4,4-dichloro-n,3-dimethyl-n-{4-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl}butanamide

C19H29Cl2N3O2S (433.1357)